Bottom line
GMBXX vs BKDV: the short answer
GMBXX (BNY Dreyfus Money Market Fund) and BKDV (BNY Mellon Dynamic Value ETF) are both money market funds.
BKDV is cheaper at 0.6% vs 1% — a difference of $40 a year per $10,000 invested.
Over one year, BKDV returned +18.4% vs +3.5% for GMBXX.
Updated Nov 19, 2026
GMBXX vs BKDV side by side
| GMBXX | BKDV | |
|---|---|---|
| Type | Money market fund | ETF |
| Fund family | BNY Mellon / Dreyfus | BNY Mellon / Dreyfus |
| Category | Money Market | Large Value |
| Expense ratio | 1% | 0.6% |
| Annual cost per $10k | $100 | $60 |
| 10-yr cost on $10k (prospectus) | $1,267 | $750 |
| Max front load | — | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +3.5% | +18.4% |
| 5-yr return (annualized) | +2.7% | — |
| 10-yr return (annualized) | +1.6% | — |
| Best quarter | +1.2% | +5.1% |
| Worst quarter | 0.0% | +2.7% |
| Net assets (fund) | — | $1.8B |
| Number of holdings | — | 81 |
| Portfolio turnover | — | 104% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GMBXX | BKDV | Difference |
|---|---|---|---|
| 2025 | +3.5% | +18.4% | −14.9% |
Source: Fund prospectus bar charts
Holdings overlap
GMBXX and BKDV share none of their top holdings.
GMBXX top 10
BKDV top 10
- Amazon.com Inc — 6.31%
- Microsoft Corp — 4.64%
- Jp Morgan Chase & Company — 4.05%
- Berkshire Hathaway Inc — 3.26%
- Unitedhealth Group Inc — 2.96%
- Johnson & Johnson — 2.76%
- Cisco Systems Inc — 2.75%
- Slb Ltd — 2.31%
- Assurant Inc — 2.19%
- Thermo Fisher Scientific Inc — 2.08%
FAQ
What is the difference between GMBXX and BKDV?
GMBXX (BNY Dreyfus Money Market Fund) and BKDV (BNY Mellon Dynamic Value ETF) are both money market funds. BKDV is cheaper at 0.6% vs 1% — a difference of $40 a year per $10,000 invested.
Which is cheaper, GMBXX or BKDV?
BKDV has the lower expense ratio (0.6%).
Should I own both GMBXX and BKDV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.